UBS analyst Joseph Spak maintained a Hold rating on Adient on October 3 and set a price target of $28.00. The company’s shares closed last Friday at $25.87.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
According to TipRanks, Spak is an analyst with an average return of -9.1% and a 47.39% success rate. Spak covers the Consumer Cyclical sector, focusing on stocks such as General Motors, Tesla, and Adient.
Currently, the analyst consensus on Adient is a Hold with an average price target of $25.62.
The company has a one-year high of $26.16 and a one-year low of $10.04. Currently, Adient has an average volume of 1.11M.
Based on the recent corporate insider activity of 35 insiders, corporate insider sentiment is negative on the stock. This means that over the past quarter there has been an increase of insiders selling their shares of ADNT in relation to earlier this year. Most recently, in August 2025, Jerome J. Dorlack, the President & CEO of ADNT sold 12,000.00 shares for a total of $273,240.00.
Read More on ADNT:
/Semiconductor%20by%20Gorodenkoff%20via%20Shutterstock.jpg)
/An%20image%20of%20a%20Tesla%20humanoid%20robot%20in%20front%20of%20the%20company%20logo%20Around%20the%20World%20Photos%20via%20Shutterstock.jpg)
